Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sisonke Boost Open Label Study
PACTR202312739012205Phase 3Unknown
- Sponsor
- South African Medical Research Council
- Start
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by South African Medical Research Council. Primary endpoints: Effectiveness on severe COVID-19, Effectiveness on COVID-19 hospitalizations and 1 more. Status: unknown.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202312739012205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202312739012205.